Creative Capital Management Investments’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$624K Buy
520
+468
+900% +$478K 0.14% 35
2026
Q1
$47.8K Sell
52
-1
-2% -$1.01K 0.01% 118
2025
Q4
$57K Buy
53
+1
+2% +$956 0.02% 112
2025
Q3
$39.7K Hold
52
0.01% 123
2025
Q2
$40.5K Hold
52
0.01% 128
2025
Q1
$42.9K Hold
52
0.02% 117
2024
Q4
$40.1K Hold
52
0.02% 118
2024
Q3
$46.1K Hold
52
0.02% 97
2024
Q2
$47.1K Buy
52
+3
+6% +$2.4K 0.02% 87
2024
Q1
$38.1K Hold
49
0.02% 99
2023
Q4
$28.6K Hold
49
0.02% 108
2023
Q3
$26.3K Hold
49
0.02% 112
2023
Q2
$23K Hold
49
0.02% 110
2023
Q1
$16.8K Buy
+49
New +$16.5K 0.01% 135

Other funds holding LLY

Creative Capital Management Investments's LLY Position: Q2 2026 in Review

Creative Capital Management Investments increased its Eli Lilly (LLY) stake by 900% in Q2 2026, buying an estimated $478K and bringing the position to 520 shares worth $624K. The position accounts for 0.14% of the portfolio, ranked #35.

Creative Capital Management Investments first reported a position in LLY in Q1 2023 and has held it in 14 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Creative Capital Management Investments held 520 shares of Eli Lilly worth $624K as of Q2 2026.
  • Creative Capital Management Investments bought 468 Eli Lilly shares in Q2 2026, an estimated $478K.
  • Eli Lilly made up 0.14% of Creative Capital Management Investments's portfolio in Q2 2026, its #35 holding.
  • Creative Capital Management Investments first reported a position in Eli Lilly in Q1 2023 and has held it in 14 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Creative Capital Management Investments's 13F filing for Q2 2026, filed 24 Jul 2026.